Polyps Clinical Trials
A listing of Polyps medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 45 clinical trials
DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations (DETERMINE)
cancer known as a METex14 skipping mutation.Investigators now wish to find out if it will be useful in treating patients with other cancer types which have the same mutation or other specific
- 0 views
- 03 Jul, 2025
- 16 locations
![Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma](/media/imagery/217282.svg)
Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma
This phase I trial tests the safety of [89Zr]DFO-YS5 positron emission tomography (PET) imaging and how well it works to detect CD46 positive cancer cells in patients with multiple myeloma. [89Zr
- 0 views
- 25 Jun, 2025
Sanofi Test Website carcinoma
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum et sapien non purus accumsan pulvinar eget ac tortor. Ut et sagittis libero, nec vestibulum quam. Aliquam non felis consectetur libero vestibulum tincidunt vitae in est.
- 0 views
- 01 Mar, 2024
- 1 location
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma
selumetinib is better than CV in improving vision in subjects with LGG of the optic pathway (vision nerves). Selumetinib is a drug that works by blocking some enzymes that low-grade glioma tumor cells need for
- 0 views
- 21 May, 2025
- 3 locations
Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma (SINE)
not respond to treatment. Drugs used in chemotherapy, such as selinexor and dexamethasone, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from
- 0 views
- 06 May, 2025
- 1 location
Modeling and characterizing early ALK-dependent tumorigenesis
insights to guide strategies for early detection, intervention, disruption of cancer progression, and ultimately to cure patients with ALK+ lung cancer. Limited access to early-stage ALK+ patient samples has
- 0 views
- 10 Jan, 2025
- 1 location
Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC
To determine the effect of a special preparation of cells, called tumor-infiltrating lymphocytes (TIL) stimulated with CD40L, when given with the drug nivolumab, for patients with EGFR, ALK, ROS1
- 0 views
- 10 Jan, 2025
- 1 location
Prophylactic Peptide Vaccine in Advanced ALK+ NSCLC
The purpose of this study is to evaluate the safety of a cancer peptide vaccine to prevent or delay acquired resistance in advanced ALK+ lung cancer patients currently on ALK targeted therapy.
- 0 views
- 10 Jan, 2025
- 1 location
A Study of Multiple Therapies in Biomarker-Selected Patients With Resectable Stages IB-III Non-Small Cell Lung Cancer
This trial will evaluate the efficacy and safety of various therapies in patients with Stage IB, IIA, IIB, IIIA, or selected IIIB resectable and untreated non-small cell lung cancer (NSCLC) tumors
- 0 views
- 10 Jan, 2025
- 26 locations